Français
ItalianoBond AbbVie 5% ( US00287YCR80 ) in USD
| Issuer | AbbVie | ||||||||||||||||||||||||||||||||
| Market price | 100 % ▼ | ||||||||||||||||||||||||||||||||
| Country |  United States
|
||||||||||||||||||||||||||||||||
| ISIN code |
 US00287YCR80 ( in USD )
|
||||||||||||||||||||||||||||||||
| Interest rate | 5% per year ( payment 2 times a year) | ||||||||||||||||||||||||||||||||
| Maturity | 12/14/2021 - Bond has expired | ||||||||||||||||||||||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||||||||||||||||||||||
| Total amount | 1 167 612 000 USD | ||||||||||||||||||||||||||||||||
| Cusip | 00287YCR8 | ||||||||||||||||||||||||||||||||
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||||
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YCR80, pays a coupon of 5% per year. The coupons are paid 2 times per year and the Bond maturity is 12/14/2021 The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YCR80, was rated Baa2 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YCR80, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||